A Phase II study of LP-003, a novel high-affinity, long-acting anti-IgE antibody for allergic rhinitis 🔗 Access full article via Journal of Allergy and Clinical ImmunologyShare:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
